Table 2. Clinicopathologic characteristics associated with neurofibromas.
Case | Age | Gender | Site | Intensity of p53 staining | % of p53+ tumor cells | P53 staining positive |
---|---|---|---|---|---|---|
1 | 61 | Female | Leg | 0 | 0% | No |
2 | 57 | Male | Back | 0 | 0% | No |
3 | 71 | Male | Chest | 0 | 0% | No |
4 | 72 | Male | Abdomen | 0 | 0% | No |
5 | 58 | Female | Face | 0 | 0% | No |
6 | 50 | Male | Neck | 0 | 0% | No |
7 | 71 | Female | Arm | 0 | 0% | No |
8 | 84 | Female | Arm | 0 | 0% | No |
9 | 85 | Male | Back | 0 | 0% | No |
10 | 73 | Male | Back | 0 | 0% | No |
11 | 28 | Male | Leg | 0 | 0% | No |
12 | 69 | Female | Arm | 0 | 0% | No |
13 | 81 | Male | Back | 0 | 0% | No |
14 | 47 | Female | Back | 0 | 0% | No |
15 | 61 | Female | Abdomen | 0 | 0% | No |
16 | 63 | Male | Arm | 0 | 0% | No |
17 | 70 | Male | Back | 0 | 0% | No |
18 | 70 | Male | Back | 0 | 0% | No |
19 | 73 | Male | Scalp | 0 | 0% | No |
20 | 60 | Female | Back | 0 | 0% | No |